The Joint Corp. (NASDAQ:JYNT) Shares Purchased by BNP Paribas Financial Markets

BNP Paribas Financial Markets increased its stake in The Joint Corp. (NASDAQ:JYNT) by 5.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,510 shares of the company’s stock after acquiring an additional 1,156 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.15% of Joint worth $258,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. FMR LLC lifted its position in shares of Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after acquiring an additional 2,971 shares in the last quarter. Squarepoint Ops LLC acquired a new position in Joint in the 2nd quarter valued at $144,000. Sargent Investment Group LLC purchased a new position in Joint in the 2nd quarter valued at $150,000. XTX Topco Ltd acquired a new stake in Joint during the 2nd quarter worth $174,000. Finally, American Century Companies Inc. grew its holdings in shares of Joint by 47.7% during the second quarter. American Century Companies Inc. now owns 24,170 shares of the company’s stock worth $340,000 after buying an additional 7,804 shares in the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

Joint Trading Up 0.8 %

Shares of JYNT stock opened at $11.11 on Tuesday. The Joint Corp. has a twelve month low of $8.88 and a twelve month high of $17.82. The company’s 50-day moving average price is $11.35 and its 200-day moving average price is $12.27. The stock has a market cap of $166.47 million, a price-to-earnings ratio of -9.75 and a beta of 1.57.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Roth Mkm decreased their price target on shares of Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. StockNews.com raised shares of Joint from a “hold” rating to a “buy” rating in a research note on Friday, November 15th.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.